use of natural human leucocyte interferon alpha cells for the therapy of viral hepatitis, cancer and primary immunodefici =

• 1. 人白细胞介素23受体在制备用于治疗癌症的药物中的用途 [P] . 中国专利： CN104689342B . 2017.05.10
• 2. 人白细胞介素23受体在制备用于治疗癌症的药物中的用途 [P] . 中国专利： CN104689342A . 2015-06-10
• 3. use of interferon alpha naturalw human lymphoblastoid cells for the therapy of viral hepatitis, cancer and immunode syndromes [P] . ITRM960136A1 . 1997-08-28

  机译： 干扰素自然人淋巴母细胞治疗病毒性肝炎，癌症和免疫综合症的用途

• 4. RECOMBINANT PLASMID plFN-amp;alpha;F-Pa CODING SYNTHESIS OF LEUCOCYTAL HUMAN INTERFERON AND STRAIN E COLI - PRODUCER OF LEUCOCYTAL HUMAN INTERFERON amp;alpha;F [P] . SU1312962A1 . 1994-12-30

  机译： 重组质粒pFN-αF-Pa编码的白细胞干扰素和大肠杆菌产生株。

• 5. RECOMBINANT PLASMID plFN-amp;alpha;A-P2 CODING SYNTHESIS OF LEUCOCYTAL HUMAN INTERFERON amp;alpha;A AND STRAIN E COLI - PRODUCER OF LEUCOCYTAL HUMAN INTERFERON [P] . SU1312961A1 . 1994-12-30

  机译： 重组质粒pFN-αA-P2编码的白细胞介素αA和应变E大肠杆菌生产者白细胞干扰素。

• 1. Therapeutic　effectiveness　of　interferon　alpha　on　hepatitis　B　virus　DNA　in　peripheral　blood　mononuclear　cells [J] . 郭亚兵, 张继锁, 侯金林, 中国人民解放军军医大学学报：英文版 . 1996,第003期
• 2. Interferons and viruses: defense and attack. Interferon and immunotherapy in counter-defense against recurrent and latent viral and viral-bacterial infections [C] . Nesterova I., Klethshenko E., Alekseeva O., World Asthma COPD Forum . 2011
• 3. The epigenetic role of microRNAs in the regulation of host tumor suppressor genes induced by hepatitis C viral infection in primary human hepatocytes. [D] . Kaliszewski, Michael S. 2010
• 4. High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment [O] . Veronica D. Gonzalez, Karolin Falconer, Kim G. Blom, 2009
• 5. Erratum: Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines.Int. J. Cancer,71, 1103–1108 (1997) [O] . Fortunata Iacopino, Gioacchino Robustelli Della Cuna, Gigliola Sica 1997

• 1. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B:A randomized controlled study [J] . Jing You ,Lin Zhuang ,Hong-Ying Cheng . 世界胃肠病学杂志：英文版 . 2006,第41期
• 2. Mutations in carboxy-terminal part of E2 including PKR/eIF2αphosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b:Their correlation with response to interferon monotherapy and viral load [J] . Koji Ukai ,Masatoshi Ishigami ,Kentaro Yoshioka . 世界胃肠病学杂志：英文版 . 2006,第23期
• 3. Combination Therapy with Pegylated Interferon alpha-2b and Adefovir Dipivoxil in HBeAg-positive Chronic Hepatitis B versus Interferon Alone: A Prospective, Randomized Study [J] . Yu-hua LIU ,Tao WU ,Ning SUN . 华中科技大学学报（医学）（英德文版） . 2014,第004期
• 4. Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C [J] . JianWang ,Gui-JuXiang ,Bing-XiangLiu . 世界胃肠病学杂志：英文版 . 2003,第4期
• 5. 人白细胞干扰素治疗慢性乙型病毒性肝炎的效果观察（摘要） [C] . 巫振欧 . 全国第五次干扰素学术会议 . 1985
• 6. 白细胞介素-18基因启动子区单核苷酸多态性与慢性丙型病毒性肝炎患者干扰素应答关系的研究 [A] . 吉木斯 . 2013